Back to Search
Start Over
Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPAR[gamma]
- Source :
- The Journal of Nutrition. March, 2010, Vol. 140 Issue 3, p515, 7 p.
- Publication Year :
- 2010
-
Abstract
- Conjugated linoleic acid (CLA) exerts a protective effect on experimental inflammatory bowel disease and shows promise as a chemopreventive agent against colorectal cancer (CRC) in mice, although the mechanisms by which it exerts its beneficial effects against malignancies in the gut are not completely understood. Mice lacking PPAR[gamma], in immune and epithelial cells and PPAR[gamma]/-expressing littermates were fed either control or CLA-supplemented (1 g CLA/100 g) diets to determine the role of PPAR[gamma], in inflammation-induced CRC. To induce tumor formation and colitis, mice were treated with azoxymethane and then challenged with 2% dextran sodium sulfate, respectively. Dietary CLA ameliorated disease activity, decreased colitis, and prevented adenocarcinoma formation in the PPAR[gamma],-expressing floxed mice but not in the tissue-specific PPAR[gamma]-null mice. Dietary CLA supplementation significantly decreased the percentages of macrophages in the mesenteric lymph nodes (MLN) regardless of the genotype and increased regulatory T cell numbers in MLN of PPAR[gamma]expressing, but not in the tissue-specific, PPAR-),-null mice. Colonic tumor necrosis factor-[alpha] mRNA expression was significantly suppressed in CLA-fed, PPAR[gamma]-expressing mice. This study suggests CLA ameliorates colitis and prevents tumor formation in part through a PPAR[gamma]-dependent mechanism. doi: 10.3945/jn.109.115642.
Details
- Language :
- English
- ISSN :
- 00223166
- Volume :
- 140
- Issue :
- 3
- Database :
- Gale General OneFile
- Journal :
- The Journal of Nutrition
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.221203549